PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.07%
Revenue growth at 50-75% of NXPI's 6.22%. Martin Whitman would worry about competitiveness or product relevance.
6.28%
Gross profit growth at 75-90% of NXPI's 7.83%. Bill Ackman would demand operational improvements to match competitor gains.
8.28%
EBIT growth 50-75% of NXPI's 13.50%. Martin Whitman would suspect suboptimal resource allocation.
8.59%
Operating income growth at 50-75% of NXPI's 13.50%. Martin Whitman would doubt the firm’s ability to compete efficiently.
9.81%
Net income growth at 50-75% of NXPI's 15.99%. Martin Whitman would question fundamental disadvantages in expenses or demand.
9.48%
EPS growth at 50-75% of NXPI's 15.90%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
9.66%
Diluted EPS growth at 50-75% of NXPI's 17.28%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
0.11%
Slight or no buybacks while NXPI is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
No Data
No Data available this quarter, please select a different quarter.
12.62%
Maintaining or increasing dividends while NXPI cut them. John Neff might see a strong edge in shareholder returns.
-2.92%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-44.64%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
73.70%
10Y revenue/share CAGR under 50% of NXPI's 202.89%. Michael Burry would suspect a lasting competitive disadvantage.
52.56%
5Y revenue/share CAGR similar to NXPI's 56.86%. Walter Schloss might see both companies benefiting from the same mid-term trends.
34.08%
3Y revenue/share CAGR at 75-90% of NXPI's 39.49%. Bill Ackman would expect new product strategies to close the gap.
198.43%
10Y OCF/share CAGR under 50% of NXPI's 2242.40%. Michael Burry would worry about a persistent underperformance in cash creation.
83.17%
5Y OCF/share CAGR above 1.5x NXPI's 34.15%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
13.33%
3Y OCF/share CAGR at 50-75% of NXPI's 18.44%. Martin Whitman would suspect weaker recent execution or product competitiveness.
782.06%
Net income/share CAGR above 1.5x NXPI's 406.93% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
120.11%
Below 50% of NXPI's 492.33%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
77.97%
3Y net income/share CAGR 50-75% of NXPI's 140.57%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
49.67%
Below 50% of NXPI's 429.03%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
37.23%
Positive 5Y equity/share CAGR while NXPI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
52.90%
Positive short-term equity growth while NXPI is negative. John Neff sees a strong advantage in near-term net worth buildup.
576.51%
Dividend/share CAGR of 576.51% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
129.41%
Dividend/share CAGR of 129.41% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
48.82%
Below 50% of NXPI's 123.57%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
2.90%
Our AR growth while NXPI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
2.52%
Inventory growth well above NXPI's 1.36%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.03%
Asset growth 1.25-1.5x NXPI's 4.27%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
9.61%
Positive BV/share change while NXPI is negative. John Neff sees a clear edge over a competitor losing equity.
6.03%
Debt growth far above NXPI's 10.21%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
0.26%
R&D dropping or stable vs. NXPI's 3.05%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-1.94%
We cut SG&A while NXPI invests at 5.76%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.